IL-7 producing whole cell vaccine is also proved to evoke an effective anti-cancer immune response, probably mediated by NK1.1+ cells for subcutaneous prostate cancer challenge [49], while the GM-CSF producing vaccine is good at intraprostatic tumor challenge [50]. The gene discussed is IL7; the disease is prostate cancer.